Table 3.
Quality of life in men and women with PAI compared to normative data.
| Total | Men | Women | p-value | ||
|---|---|---|---|---|---|
| Patients with PAI | |||||
| AddiQoL-30 mean ± SD (no) | 83 ± 14 (72) | 89 ± 13 (29) | 80 ± 13 (43) | 0.005* | |
| AddiQoL-8 mean ± SD (no) | 20 ± 5 (72) | 22 ± 4 (29) | 18 ± 5 (43) | 0.003* | |
| PCS median [IQR] (no) | 52 [44-59] (482) | 54 [48-60] (184) | 49 [41-57] (298) | <0.001* | |
| MCS median [IQR] (no) | 52 [44-57] (482) | 54 [48-58] (184) | 51 [42-56] (298) | 0.002* | |
| Normative data | |||||
| PCS median [IQR] (no) | 53 [47-57] (5048) | 53 [48-57] (2466) | 52 [46-56] (2582) | <0.001* | |
| MCS median [IQR] (no) | 54 [46-57] (5048) | 54 [47-57] (2466) | 53 [44-57] (2582) | <0.001* |
PAI, primary adrenal insufficiency; PCS, physical component summary; MCS, mental component summary. *; statistically significant defined as p < 0.010.